XENE Q2 2017 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15,000-96.4% YoY

Gross Profit

-$6M-40626.7% margin

Operating Income

-$8M-52620.0% margin

Net Income

-$7M-49200.0% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$598,000

Balance Sheet

Total Assets

$54M

Total Liabilities

$4M

Stockholders' Equity

$50M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15,000	$413,000	-96.4%
Gross Profit	-$6M	$71,000	-8683.1%
Operating Income	-$8M	-$6M	-24.0%
Net Income	-$7M	-$6M	-22.7%